Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Delivers 200,000 SNP Assays to RIKEN

NEW YORK, Dec 2 (GenomeWeb News) - Third Wave Technologies has delivered 200,000 Invader SNP assays to the Japanese Institute for Physical and Chemical Research (RIKEN) for use in the international HapMap haplotyping project and other large-scale genotyping projects, the company said today.

Third Wave said it began delivering the assays in early 2003, and would continue to provide RIKEN with SNP assays for its ongoing work on the HapMap initiative. Yusuke Nakamura, group director of the Research Group for Personalized Medicine at RIKEN, is responsible for completing 25 percent of the HapMap project, Third Wave said.

The company said it is also providing RIKEN with Invader assays for other genotyping projects, such as the BioBank Japan project, which plans to genotype around 300,000 Japanese individuals over the next five years.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.